Skip to content

MELO SOINS

Active
Private limited companyfounded 2024active for 1 yearRue des Pavillons 8, 6150 Anderlues, BelgiumKBO/BCE: BE 1017.055.490
Summary

MELO SOINS has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,513 and a net result of €42,965. Its solvency ranks better than 81% of 20,736 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 06-12-2024 Normal situation
Activity
Nursing and midwifery NACE 86940
Establishment unit
2.368.804.435 6150 Anderlues, since 06-12-2024
Financial year end
31 December
Peppol
Reachable since 27-05-2025

Board and ownership

Shareholders
  • LIEMANS Mélodie, Marie-Madeleinedeed of 10-12-2024

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€55,475
▲ 142%
Turnover
≈ €150,000
estimated
Profit
€42,965
▲ 176%
Equity
€60,513
▲ 245%
Total assets
€68,462
▲ 169%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 8.37, cash €53,723Equity €60,513 (88.4% of total assets)Figures for financial year 2025 (filed on 29-06-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 87% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+6
equity 88.4% of total assets
Liquidity 99+12
short-term debt 11.6% · cash 78.5%
Profitability 100=
return on assets 62.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 01-2026: < 0.1% 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026highest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 8.37 (3.23 in 2024), above the usual 1.5. Short-term debt is 11.6% and cash 78.5% of total assets. 11.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 89% on liquidity, 80% on profitability and 96% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 8.37, cash €53,723
NBB · annual accounts
lowers risk · Equity €60,513 (88.4% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 29-06-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
32 days early
2024
14 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 23 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Positive: Higher solvency than 81% of companies in human healthsector median 63.0% · 20,736 companies 88.4% View

Recent changes

  1. · Gazette deed IncorporationFounding capital of €2,000, 100 shares · Founder: LIEMANS Mélodie, Marie-Madeleine · Appointment: LIEMANS Mélodie, Marie-Madeleine (director)
All 4 events

Comparable companies

These companies have the same main activity as MELO SOINS: nursing and midwifery (NACE 86940). They are comparable in size and age: total assets between €58,600 and €76,500, founded between 2024 and 2025.

CompanyTotal assetsGross margin
MELO SOINS Anderlues€68,462€55,475
LIPAMBOLI Mons€69,951€52,837
SPARADRAP Tournai€58,881€53,479
CHARPENTIER ELODIE Dour€58,635€58,784
Ngassa Care Roeselare€71,494€51,891
A.D HEALTH CARE Aalst€76,546€57,450
Thuisverpleging Evelyn Merveillie Veurne€58,978€56,566
Full comparison

Key facts about MELO SOINS

What is the company number of MELO SOINS?
The company number of MELO SOINS is 1017.055.490. The VAT number is the same number with BE in front: BE 1017.055.490.
Where is MELO SOINS based?
The registered office is at Rue des Pavillons 8, 6150 Anderlues.Company details
What does MELO SOINS do?
According to the KBO register, the main activity is nursing and midwifery (NACE 86940).
What is the legal form of MELO SOINS?
MELO SOINS is a private limited company (BV).
When was MELO SOINS founded?
MELO SOINS was founded on 06-12-2024.
Is MELO SOINS still active?
Yes, MELO SOINS is an active enterprise in the KBO register.
What is the turnover of MELO SOINS?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €55,475 and 33 comparable companies (NACE 869). It probably lies between €99,000 and €230,000.Financials
Is MELO SOINS profitable?
In financial year 2025, MELO SOINS made a profit of €42,965.
Where can I find the annual accounts of MELO SOINS?
MELO SOINS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MELO SOINS due?
MELO SOINS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.